Posted in Policy / Pricing Pharma’s Reluctance To Serve Europe To Dodge MFN Drug Pricing Is Chilling April 2, 2026 BioSpace As Big Pharma companies consider foregoing European drug launches to avoid reducing drug prices in the U.S. Policy / PricingRead full story